Steve Berman

Steve Berman has an extensive background in science, regulatory affairs, and policy development within the biotechnology and pharmaceutical industry. With experience in roles such as Deputy Vice President at Biotechnology Innovation Organization, Director at AstraZeneca, and Science Policy Analyst at FDA, Steve has led various initiatives to promote biomedical innovation and streamline regulatory processes. Steve holds a BS in Molecular Biology from Cornell University and an MPH from Columbia University.